Onyx Scientific Targets Stateside Expansion with New Appointment

Leading small molecule CDMO Onyx Scientific is set to expand its commercial operations in the United States with the appointment of Anthony Harbour as Business Development Manager in North America to lead the company's ambitious US growth plans.

Onyx Scientific has had a successful track record in the US market over several years. This has been a key factor behind the company’s recent growth, which saw an increase in its non-GMP scale-up and GMP manufacturing capacity by 50% and also saw the company headcount grow by over 50% to 120 employees over the last 2-3 years.

With this new business development appointment, Onyx Scientific is looking to significantly increase its market share in the US, strengthen its future growth prospects, and maintain its commitment to providing exceptional customer service to its international clients.

Anthony Harbour is a seasoned industry professional with specialist expertise in biopharma and biotech and extensive experience in amplifying product revenues and market share across the industry.

Prior to joining the team at Onyx Scientific Anthony previously held sales and business development roles at Alevi and ParaPRO LLC based in North America. In his role at Alevi, he was responsible for working with academia and pharmaceutical companies to deliver bioprinting equipment across the East Coast in the USA, Canada, and Latin America. At ParaPRO LLC he managed 150 territorial accounts with the top 20 pharma providers in the US.

Commenting on the new appointment, Onyx Scientific Commercial Manager Dr Chris Atherton said: “The appointment of Anthony Harbour as our Business Development Manager marks the latest phase of our expansion in the US market. He has a proven track record of seamlessly integrating his scientific knowledge with business management experience and sales acumen to drive forward commercial growth.

“Anthony brings adept negotiation skills, creative marketing abilities, and capacity for high-level engagements with clients. He will play a pivotal role in achieving Onyx Scientific’s future growth targets across the pond.”

Anthony Harbour Onyx Scientific’s new Business Development Manager added “I’m looking forward to the new challenge of expanding Onyx Scientific’s current commercial footprint in the United States, and spearheading the company’s future growth in the North American market. Having worked extensively across multiple territories and time zones across North America, my knowledge and expertise of the local and national market in the US will enable me to hit the ground running in this role. I am committed to harnessing the power of Onyx Scientific's existing client base and forging new strategic relationships through my work with the company. Onyx Scientific has enjoyed significant growth in recent years, and I’m passionate about being part of the next phase of the business’s expansion.

You can find more information about Onyx Scientific here